{{Rsnum
|rsid=2286720
|Gene=LYZL4
|Chromosome=3
|position=42406979
|Orientation=plus
|GMAF=0.1208
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=LYZL4
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 1.8 | 19.6 | 78.6
| HCB | 8.0 | 43.8 | 48.2
| JPT | 12.4 | 37.2 | 50.4
| YRI | 0.0 | 1.4 | 98.6
| ASW | 0.0 | 3.5 | 96.5
| CHB | 8.0 | 43.8 | 48.2
| CHD | 7.3 | 45.9 | 46.8
| GIH | 0.0 | 27.7 | 72.3
| LWK | 0.0 | 0.0 | 0.0
| MEX | 1.7 | 12.1 | 86.2
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 16.7 | 83.3
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21107309
|Trait=None
|Title=Genome-Wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia
|RiskAllele=
|Pval=0.000001
|OR=None
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}